Discovery of PPARγ and glucocorticoid receptor dual agonists to promote the adiponectin and leptin biosynthesis in human bone marrow mesenchymal stem cells
- Eur J Med Chem. 2023 Jan 5;245(Pt 1):114927. doi: 10.1016/j.ejmech.2022.114927.
- 1. College of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul, 08826, Republic of Korea.
- 2. College of Pharmacy, Korea University, 2511 Sejong-ro, Sejong, 30019, Republic of Korea.
- 3. Uimyung Research Institute for Neuroscience, Sahmyook University, 26-21 Kongreung-2-dong, Hwarangro-815, Nowon-gu, Seoul, 139-742, Republic of Korea.
- 4. School of Pharmacy, Jeonbuk National University, Jeonju, 54896, Republic of Korea.
- 5. College of Pharmacy, Korea University, 2511 Sejong-ro, Sejong, 30019, Republic of Korea. Electronic address: [email protected].
- 6. College of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul, 08826, Republic of Korea. Electronic address: [email protected].
Adiponectin and Leptin are major adipocytokines that control crosstalk between adipose tissue and Other organ systems. Hypoadiponectinemia and hypoleptinemia are associated with human metabolic diseases. Compounds with adipocytokine biosynthesis-stimulating activities could be developed as therapeutics against diverse metabolic conditions. In phenotypic screening with human bone marrow mesenchymal stem cells (hBM-MSCs), (E)-4-hydroxy-3-(3-(4-hydroxy-3-methoxyphenyl)acryloyl)-6-methyl-2H-pyran-2-one (1) was identified to increase Adiponectin biosynthesis during adipogenesis and simultaneously to stimulate Leptin production. Using the compound 1 structure, the structure-activity relationship study was performed to discover more potent compounds stimulating both Adiponectin and Leptin production. (E)-3-(3-(2-fluoropyridin-4-yl)acryloyl)-4-hydroxy-6-methyl-2H-pyran-2-one (11) exhibited the most potent Adiponectin (EC50, 2.87 μM) and Leptin (EC50, 2.82 μM) biosynthesis-stimulating activities in hBM-MSCs. In a target identification study, compound 11 was characterized as a dual modulator binding to both Peroxisome Proliferator-activated Receptor (PPAR) γ and Glucocorticoid Receptor (GR). This study provides a novel pharmacophore for PPARγ/GR dual modulators with therapeutic potential against human metabolic diseases.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Metabolic Disease